statistiche per ROLANDO, Barbara

Distribuzione geografica

Continente	#
NA - Nord America	4595
EU - Europa	2832
AS - Asia	1600
OC - Oceania	30
AF - Africa	24
SA - Sud America	19
Continente sconosciuto - Info sul continente non disponibili	5
Totale	9105

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	4498
CN - Cina	1034
IT - Italia	852
DE - Germania	328
SE - Svezia	256
UA - Ucraina	250
GB - Regno Unito	216
FR - Francia	189
PL - Polonia	160
FI - Finlandia	154
KR - Corea	149
AT - Austria	147
VN - Vietnam	145
DK - Danimarca	128
CA - Canada	88
JP - Giappone	80
IN - India	59
TW - Taiwan	39
RU - Federazione Russa	36
ES - Italia	24
AU - Australia	21
GR - Grecia	21
NL - Olanda	20
TR - Turchia	19
CH - Svizzera	13
HK - Hong Kong	12
SN - Senegal	12
UZ - Uzbekistan	10
BR - Brasile	9
ID - Indonesia	9
NZ - Nuova Zelanda	9
MX - Messico	8
AE - Emirati Arabi Uniti	6
CZ - Repubblica Ceca	6
IR - Iran	6
TH - Thailandia	6
EU - Europa	5
AL - Albania	4
AR - Argentina	4
EG - Egitto	4
HU - Ungheria	4
JO - Giordania	4
MY - Malesia	4
NO - Norvegia	4
PT - Portogallo	4
SG - Singapore	4
IE - Irlanda	3
IL - Israele	3
PK - Pakistan	3
RO - Romania	3
SA - Arabia Saudita	3
ZA - Sudafrica	3
BE - Belgio	2
BG - Bulgaria	2
CL - Cile	2
CY - Cipro	2
EC - Ecuador	2
IQ - Iraq	2
MU - Mauritius	2
SC - Seychelles	2
UY - Uruguay	2
AZ - Azerbaigian	1
BZ - Belize	1
HR - Croazia	1
LV - Lettonia	1
MK - Macedonia	1
MW - Malawi	1
RS - Serbia	1
SI - Slovenia	1
SK - Slovacchia (Repubblica Slovacca)	1
Totale	9105

Salva come PNG Salva come JPEG

Città	#
Ann Arbor	752
Fairfield	632
Beijing	494
Woodbridge	332
Torino	321
Houston	316
Seattle	259
Ashburn	230
Wilmington	224
Cambridge	204
Jacksonville	173
Pisa	172
Dearborn	162
Warsaw	153
Vienna	143
Redwood City	121
Villeurbanne	114
Dong Ket	109
Fremont	59
Hangzhou	56
Munich	51
Shanghai	49
Guangzhou	39
Nanjing	37
Taipei	35
San Diego	32
Ottawa	31
Toronto	28
Milan	27
Shenyang	24
Tokyo	23
Jinan	22
Zhengzhou	21
Verona	19
Leinì	18
Siena	18
Wuhan	18
Xian	18
Hefei	17
Phoenix	16
Kunming	14
Seongnam	14
Changsha	13
Nanchang	13
Norwalk	13
Hebei	12
Lansing	12
Seoul	12
Buffalo	10
Chengdu	10
Lachine	10
Silver Spring	10
Central District	9
Changchun	9
Catania	8
Florence	8
Mountain View	8
Nottingham	8
Nürnberg	8
Rome	8
Toledo	8
Bologna	7
Fuzhou	7
Tianjin	7
Dallas	6
Jakarta	6
Newcastle	6
Ardabil	5
Carmagnola	5
Copenhagen	5
Nanning	5
Nashville	5
Woodside	5
Amsterdam	4
Bari	4
Chioggia	4
Chongqing	4
Düsseldorf	4
Fort Lauderdale	4
Fort Worth	4
Haikou	4
Kharkiv	4
Menlo Park	4
Monmouth Junction	4
Napoli	4
Orlando	4
Piossasco	4
Riverton	4
Sagamihara	4
Sevilla	4
Angers	3
Arezzo	3
Athens	3
Atripalda	3
Avellino	3
Baotou	3
Birmingham	3
Brisbane	3
Buenos Aires	3
Cattolica	3
Totale	5953

Salva come PNG Salva come JPEG

Nome	#
1,2,5-Oxadiazole analogues of leflunomide and related compounds	387
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance	324
Quinone based nitric oxide donating compounds	322
In vitro pharmacological evaluation of multitarget agents for thromboxane prostanoid receptor antagonism and COX-2 inhibition	270
Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance	252
New furoxan derivatives for the treatment of ocular hypertension	230
Designing Multitarget Anti-inflammatory Agents: Chemical Modulation of the Lumiracoxib Structure toward Dual Thromboxane Antagonists-COX-2 Inhibitors.	224
Overcoming multidrug resistance by targeting mitochondria with NO-donating doxorubicins	223
NO-donor thiacarbocyanines as multifunctional agents for Alzheimer’s disease	221
Mitochondrial-targeting nitrooxy-doxorubicin: a new approach to overcome drug resistance.	185
Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts	184
Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors	178
A new series of amodiaquine analogues modified in the basic side chain with in vitro antileishmanial and antiplasmodial activity	172
Edaravone derivatives containing NO-donor functions	165
An Autocrine Cytokine/JAK/STAT-Signaling Induces Kynurenine Synthesis in Multidrug Resistant Human Cancer Cells	161
Carnosine analogues containing NO-donor substructures: Synthesis, physico-chemical characterization and preliminary pharmacological profile	151
Doxorubicin-antioxidant multitarget drugs	149
A Molecular Hybrid for Mitochondria-Targeted NO Photodelivery	149
4-Hydroxy-1,2,5-oxadiazol-3-yl Moiety as Bioisoster of the Carboxy Function. Synthesis, Ionization Constants, and Molecular Pharmacological Characterization at Ionotropic Glutamate Receptors of Compounds Related to Glutamate and Its Homologues	144
Synthesis physicochemical profile and PAMPA study of new NO-donor edaravone co-drugs	138
Liposomal Nitrooxy-Doxorubicin: One Step over Caelyx in Drug-Resistant Human Cancer Cells	135
New nitric oxide or hydrogen sulfide releasing aspirins	131
A Nonmetal-Containing Nitric Oxide Donor Activated with Single-Photon Green Light	114
Nitrooxymethyl-Substituted Analogues of Rofecoxib: Synthesis and Pharmacological Characterization	108
Amodiaquine analogues containing NO-donor substructures: Synthesis and their preliminary evaluation as potential tools in the treatment of cerebral malaria	107
NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5-diarylimidazoles endowed with COX-2 inhibitory and vasodilator properties	107
Searching for new NO-donor Aspirin-like molecules: a new class of nitrooxy-acyl derivatives of salicylic acid	106
Nitrooxymethyl Substituted Analogues of Celecoxib: Synthesis and Pharmacological Characterization	106
Anti-pseudomonas activity of 3-nitro-4-phenylfuroxan	104
Novel Antioxidant Agents Deriving From Molecular Combination of Vitamin C and NO-donor moieties	103
Water-Soluble Nitric-Oxide-Releasing Acetylsalicylic Acid (ASA) Prodrugs	100
Synthesis and preliminary pharmacological characterisation of a new class of nitrogen-containing bisphosphonates (N-BPs)	100
Multitarget Drugs: Focus on the NO-donor hybrid drugs	98
NO-Donor Melatonin Derivatives: Synthesis And In Vitro Pharmacological Characterization	97
Nitric Oxide Donor Doxorubicins Accumulate into Doxorubicin-Resistant Human Colon Cancer Cells Inducing Cytotoxicity	96
Searching for new NO-donor aspirin-like molecules: furoxanylacyl derivatives of salicylic acid and related furazans	96
A multi-photoresponsive molecular-hybrid for dual-modal photoinactivation of cancer cells	96
Novel R-roscovitine NO-donor hybrid compounds as potential pro-resolution of inflammation agents	92
New praziquantel derivatives containing NO-donor furoxans and related furazans as active agents against Schistosoma mansoni	85
Coencapsulation of disulfiram and doxorubicin in liposomes strongly reverses multidrug resistance in breast cancer cells	79
(Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins	79
gem-Dinitroalkyl Benzenes: A Novel Class of IOP-Lowering Agents for the Treatment of Ocular Hypertension	75
A molecular hybrid producing simultaneously singlet oxygen and nitric oxide by single photon excitation with green light	74
Carnosine analogues containing Phenol substructures	71
Tuning the Hydrophobicity of a Mitochondria-Targeted NO Photodonor	71
Validation of Thiosemicarbazone Compounds as P-Glycoprotein Inhibitors in Human Primary Brain-Blood Barrier and Glioblastoma Stem Cells	71
null	70
A new class of NO-donor H3-Antagonists	68
New tetrahydroisoquinoline-based P-glycoprotein modulators: Decoration of the biphenyl core gives selective ligands	66
Curcumin-loaded solid lipid nanoparticles bypass p-glycoprotein mediated doxorubicin resistance in triple negative breast cancer cells	66
Searching for Balanced Hybrid NO-Donor 1,4-Dihydropyridines with Basic Properties	65
Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors	64
Mitochondrial delivery of phenol substructure triggers mitochondrial depolarization and apoptosis of cancer cells	62
Hyperglycemia Promotes Chemoresistance Through the Reduction of the Mitochondrial DNA Damage, the Bax/Bcl-2 and Bax/Bcl-XL Ratio, and the Cells in Sub-G1 Phase Due to Antitumoral Drugs Induced-Cytotoxicity in Human Colon Adenocarcinoma Cells.	62
Different multitarget approaches to manage coxibs associatedcardiovascular risk. Design and synthesis of new lumiracoxibderivatives	59
Amphiphilic NO-Donor Antioxidants	59
NO-DONOR 1,4-DIHYDROPYRIDINE ANALOGUES OF AMLODIPINE	57
Bioisosteres of Indomethacin as Inhibitors of Aldo-Keto Reductase 1C3	57
EFFICIENTLY TARGETING DRUG EFFLUX THROUGH MODULATION OF P-GLYCOPROTEIN ACTIVITY BY SMALL MOLECULES: DESIGN, BIOLOGICAL AND COMPUTATIONAL STUDY.	57
Physicochemical profiling of Sartans: detailed study of ionisation constants and distribution coefficients	57
4-Hydroxy-1,2,3-triazole moiety as bioisostere of the carboxylic acid function: a novel scaffold to probe the orthosteric γ-aminobutyric acid receptor binding site	55
PREPARATION AND CHARACTERIZATION OF LIPOSOMES CONTAINING A NEW ANTHRACYCLINE DERIVATIVE	54
NO-Donor Furoxans Containing a Sulphonamide Moiety and Related Furazans as Potent Carbonic Anhydrase Inhibitors	52
Aceclofenac-galactose conjugate: design, synthesis, characterization and pharmacological and toxicological evaluations	52
No-donor phenols: a study of their antioxidant activity	52
Novel amphiphilic nitric oxide releasing antioxidants: NMR spectroscopic study of their interaction with biomembrane models	52
Multitarget Drugs: No-Donor Doxorubicins	51
Synthesis, physico-chemical characterization, andbiological activities of new carnosine derivatives stablein human serum as potential neuroprotective agents	51
Identification of 2,3-diaminophenazine and of o-benzoquinone dioxime as the major in vitro metabolites of benzofuroxan	50
NITRIC OXIDE DONOR DOXORUBICINS: A USEFUL STRATEGY TO ADDRESS THE PROBLEM OF MDR IN CANCER THERAPY	48
Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma	48
Nitrooxy-doxorubicin: A New Weapon Against Multidrug Resistance.	47
MRP5 nitration by NO-releasing gemcitabine encapsulated in liposomes confers sensitivity in chemoresistant pancreatic adenocarcinoma cells	47
DNA-targeted NO release photoregulated by green light	46
One molecule two goals: A selective P-glycoprotein modulator increases drug transport across gastro-intestinal barrier and recovers doxorubicin toxicity in multidrug resistant cancer cells	46
NOVEL SEMISYNTHETIC DOXORUBICINS WITH REDUCED CARDIOTOXICITY	45
Hydroxyazole scaffold-based Plasmodium falciparum dihydroorotate dehydrogenase inhibitors: Synthesis, biological evaluation and X-ray structural studies	45
Design, Biological Evaluation, and Molecular Modeling of Tetrahydroisoquinoline Derivatives: Discovery of A Potent P-Glycoprotein Ligand Overcoming Multidrug Resistance in Cancer Stem Cells	45
NO-donor Carnosine Derivatives As Potential Neuroprotective Agents	44
Evaluation of the targeting ability of folate containing liposomal nitrooxy-doxorubicin.	43
MODIFIED DOXORUBICINS: "GASEOUS APPROACH" TO OVERCOME CARDIOTOXICITY AND MULTIDRUG RESISTANCE	42
Vasodilating profile of a new series of analogues of GTN	42
Identification of 2,3-diaminophenazine and o-benzoquinone dioxime as the major in vitro metabolites of benzofuroxan	42
Novel NO-donor Doxorubicins	41
Synthesis of NO-Donor Bisphosphonates and Their in Vitro Action on Bone Resorption	41
New No-donor aspirin derivatives	37
Focus on recent approaches for the development of new NO-donors	37
INCAPSULATED NO-GEMCITABINE: GASEOUS SOLUTION FOR MDR PANCREATIC CANCER	36
New 1,4-dihydropyridines endowed with NO-donor and calcium channel agonist properties	35
Unsymmetrically Substituted Furoxans. Part 19. Methyl and Phenylfuroxansulfonic Acids and Related Sulfonamides	35
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold: SAR of the Biphenyl Moiety	34
New class of NO-donor soluble aspirins	33
Hydroxy-1,2,5-oxadiazolyl moiety as bioisoster of the carboxy function. Sunthesis, ionization constants, and pharmacological characterisation of gamma-aminobutyric acid (GABA) related compounds	33
Identification of 2,3-diaminophenazine and of o-benzoquinone dioxime as hte major in vitro metabolites of benzofuroxan	33
Physicochemical profile and in vitro permeation behavior of a new class of non-steroidal anti-inflammatory drug candidates	32
Structure-Antioxidant Activity Relationships in a Series of NO-Donor Phenols	31
Preparation and characterization of liposomes containing a new anthracycline derivative.	30
Multitarget drugs: NO-donor doxorubicins	28
Furoxan nitric oxide donors disperse Pseudomonas aeruginosa biofilms, accelerate growth, and repress pyoverdine production	28
Extracellular matrix composition modulates the responsiveness of differentiated and stem pancreatic cancer cells to lipophilic derivate of gemcitabine	28
Totale	9270

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	9515
article - articoli	0
book - libri	0
conference - conferenze	1021
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	10536

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2016/2017	299	0	0	0	0	0	0	0	0	0	0	234	65
2017/2018	1293	77	136	73	69	89	30	79	187	291	140	49	73
2018/2019	1360	41	33	58	43	68	83	82	196	49	153	399	155
2019/2020	2383	82	89	130	288	167	282	238	181	272	281	196	177
2020/2021	1741	126	135	109	108	150	106	121	137	216	153	128	252
2021/2022	1793	117	119	162	215	118	82	147	134	80	165	454	0
Totale													9515

CINECA IRIS Institutional Research Information System

statistiche per ROLANDO, Barbara